Good IgA Bad IgG in SARS-CoV-2 Infection?
作者信息
Béné Marie C, de Carvalho Bittencourt Marcelo, Eveillard Marion, Le Bris Yannick
机构信息
Hematology Biology, Nantes University Hospital & CRCINA, Nantes, France.
Immunology Laboratory, Nancy University Hospital & IMOPA UMR7365, Nancy, France.
出版信息
Clin Infect Dis. 2020 Jul 28;71(15):897-898. doi: 10.1093/cid/ciaa426.
Abstract
摘要
相似文献
1
Good IgA Bad IgG in SARS-CoV-2 Infection?新冠病毒感染中IgA有益而IgG有害？
Clin Infect Dis. 2020 Jul 28;71(15):897-898. doi: 10.1093/cid/ciaa426.
2
Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学检测对新型冠状病毒肺炎（COVID-19）血液透析患者是否有意义？
Am J Kidney Dis. 2020 Oct;76(4):598. doi: 10.1053/j.ajkd.2020.06.006. Epub 2020 Jun 27.
3
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
4
[The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].[抗SARS-CoV-2-IgG的流行率为1.2%——德国（北莱茵-威斯特法伦州）无症状门诊患者筛查]
MMW Fortschr Med. 2020 Aug;162(14):44-46. doi: 10.1007/s15006-020-0750-y.
5
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2.SARS-CoV-2 引起的 COVID-19 肺炎患者的死亡预测因子。
Eur Respir J. 2020 Sep 24;56(3). doi: 10.1183/13993003.02961-2020. Print 2020 Sep.
6
Acute Parotitis: A Possible Precocious Clinical Manifestation of SARS-CoV-2 Infection?急性腮腺炎：新型冠状病毒肺炎感染可能出现的早熟临床表现？
Otolaryngol Head Neck Surg. 2020 Jul;163(1):182-183. doi: 10.1177/0194599820926992. Epub 2020 May 5.
7
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?新型冠状病毒2型感染并发炎症综合征。静脉注射用大剂量人免疫球蛋白（IVIG）是否有益？
Autoimmun Rev. 2020 Jul;19(7):102559. doi: 10.1016/j.autrev.2020.102559. Epub 2020 May 1.
8
COVID SARS-II Philately.新冠病毒（严重急性呼吸综合征冠状病毒2型）集邮
J Assoc Physicians India. 2020 Jun;68(6):67.
9
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.三种用于检测抗SARS-CoV-2抗体的商用自动化检测方法的评估
Clin Chem. 2020 Oct 1;66(10):1351-1353. doi: 10.1093/clinchem/hvaa193.
10
Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.新冠肺炎患者不同严重程度的新冠病毒抗体反应。
PLoS One. 2020 Oct 9;15(10):e0240502. doi: 10.1371/journal.pone.0240502. eCollection 2020.
引用本文的文献
1
Impact of social distancing from the COVID-19 pandemic on the immuno-inflammatory response of older adults.新冠疫情期间社交距离措施对老年人免疫炎症反应的影响。
BMC Geriatr. 2024 Jan 26;24(1):99. doi: 10.1186/s12877-024-04699-7.
2
Strong SARS-CoV-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Hematopoietic Stem Cell Recipients.异基因造血干细胞受者接种一剂或两剂 COVID-19 疫苗加强针后强烈的 SARS-CoV-2 T 细胞反应。
Cells. 2022 Sep 27;11(19):3010. doi: 10.3390/cells11193010.
3
Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients.不同的免疫特征有助于维持 COVID-19 轻症患者的唾液分泌型免疫球蛋白 A 产生。
Front Immunol. 2022 May 24;13:890887. doi: 10.3389/fimmu.2022.890887. eCollection 2022.
4
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.抗 SARS-CoV-2 滴度预测 COVID-19 的严重程度。
Viruses. 2022 May 18;14(5):1089. doi: 10.3390/v14051089.
5
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.康复的 COVID-19 患者中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）刺突蛋白特异性和中和抗体的长期持久性。
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
6
Assessment of severity and mortality of COVID-19 with anti-A1 and anti-B IgM isohaemagglutinins, a reflection of the innate immune status.用抗-A1 和抗-B IgM 同种血凝素评估 COVID-19 的严重程度和死亡率，反映固有免疫状态。
Int J Clin Pract. 2021 Nov;75(11):e14624. doi: 10.1111/ijcp.14624. Epub 2021 Jul 29.
7
Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG.三名新冠肺炎患者针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）结构蛋白的纵向抗体动态显示IgA、IgM和IgG同时产生。
J Inflamm Res. 2021 Jun 14;14:2497-2506. doi: 10.2147/JIR.S313188. eCollection 2021.
8
In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.在鼻腔黏膜分泌物中，严重和轻度 SARS-CoV-2 感染中存在不同的 IFN 和 IgA 反应。
Front Immunol. 2021 Feb 25;12:595343. doi: 10.3389/fimmu.2021.595343. eCollection 2021.
9
Comparison of clinical characteristics of COVID-19 between elderly patients and young patients: a study based on a 28-day follow-up.老年患者与年轻患者新型冠状病毒肺炎临床特征比较：一项基于28天随访的研究
Aging (Albany NY). 2020 Oct 26;12(20):19898-19910. doi: 10.18632/aging.104077.
10
Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.两种在不同场景下检测新型冠状病毒2型抗体的血清学方法：一种筛查工具和一种即时检测方法。
Diagn Microbiol Infect Dis. 2020 Dec;98(4):115167. doi: 10.1016/j.diagmicrobio.2020.115167. Epub 2020 Aug 11.
Zotero 插件